Skip to content

The effect of Zofa (Nepeta bracteata Benth) syrup on the allergic rhinitis disease

Assessment of the effect of Zofa (Nepeta bracteata Benth) Syrup on allergic rhinitis symptoms

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013122615943N1
Enrollment
66
Registered
2015-02-04
Start date
2014-12-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Allergic rhinitis. Condition 2: Other allergic rhinitis. Other seasonal allergic rhinitis Other allergic rhinitis

Interventions

Intervention 1: Zofa (Hyssop ) syrup, three times a day, each time 10 cc for four weeks. Intervention 2: Placebo syrup, three times a day each time 10 cc for four weeks.
Treatment - Drugs
Placebo
Zofa (Hyssop ) syrup, three times a day, each time 10 cc for four weeks
Placebo syrup, three times a day each time 10 cc for four weeks

Sponsors

shahed University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Male and female patients aged 18 to 65 years with symptoms of allergic rhinitis; not taking of medicine commonly used allergic rhinitis for at least two weeks prior to admission; having of seasonal allergic rhinitis and perennial (intermittent and continuous); having criteria for allergic rhinitis based on the ARIA questionnaire; affected to mild allergic rhinitis. Exclusion criteria: Chronic diseases such as asthma, cancer; taking any medication known to affect chemical and herbal on allergic rhinitis; recent trauma to the nose; recent surgery of the nose; people exposed to irritants; pregnancy and lactation; the risk of epilepsy; vasomotor rhinitis; alpha-blocker drugs administration; the symptoms of acute sinusitis; taking systemic immunosuppressive therapy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sneezing. Timepoint: Before and four weeks after intervention. Method of measurement: ARIA Questionnaire And VAS.;Nasal obstruction. Timepoint: Before and four weeks after intervention. Method of measurement: ARIA Questionnaire And VAS.;Rhinorrhea. Timepoint: Before and four weeks after intervention. Method of measurement: ARIA Questionnaire And VAS.;Watery ,itchy ,red eyes. Timepoint: Before and four weeks after intervention. Method of measurement: ARIA Questionnaire And VAS.;Itchy nose. Timepoint: Before and four weeks after intervention. Method of measurement: ARIA Questionnaire And VAS.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Reza Haji heydari

Shahed University of Medical Sciences

drmhajiheydari@gmail.com+98 21 2288 2521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026